The Cost Effectiveness of Docetaxel and Active Symptom Control versus Active Symptom Control Alone for Refractory Oesophagogastric Adenocarcinoma: Economic Analysis of the COUGAR-02 Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2016 AND VI 34 AND IP 1
Results: 8
1
2
Cost-of-Illness Studies: An Updated Review of Current Methods.
- Published in:
- 2016
- By:
- Publication type:
- journal article
3
Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries.
- Published in:
- 2016
- By:
- Publication type:
- journal article
4
Cost Effectiveness of Ofatumumab Plus Chlorambucil in First-Line Chronic Lymphocytic Leukaemia in Canada.
- Published in:
- 2016
- By:
- Publication type:
- journal article
5
The Irish Cost-Effectiveness Threshold: Does it Support Rational Rationing or Might it Lead to Unintended Harm to Ireland's Health System?
- Published in:
- 2016
- By:
- Publication type:
- journal article
6
Myths and Misconceptions of Within-Cycle Correction: A Guide for Modelers and Decision Makers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
7
Health Technology Assessment as a Priority-Setting Tool for Universal Health Coverage: The Call for Global Action at the Prince Mahidol Award Conference 2016.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
8
Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from Celgene.
- Published in:
- 2016
- By:
- Publication type:
- journal article